ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs MXN
20.6314
0.00%
Brent Oil
76.495
0.00%
Bitcoin
98,247.83
0.04%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Alemania
  5. TG

  6. Softing (SYT) Cotización

Softing

Softing (SYT)

Syntonic Limited
SYLA Technologies Company Ltd
3.20
0.04
(1.27%)
Cerrado 05 Enero 3:00PM
Realtime Data

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
3.20
Postura de Compra
3.12
Postura de Venta
3.28
Volume Operado de la Acción
5
3.08 Rango del Día 3.28
2.86 Rango de 52 semanas 5.75
Capitalización de Mercado [m]
29.137M
Precio Anterior
3.16
Precio de Apertura
3.08
Hora
1
@
3.28
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
2,896
Acciones en circulación
9,105,291
Rendimiento del Dividendo
4.06%
Ratio Precio/Utilidad
-10.47
Beneficio por acción (BPA)
-0.64
turnover
113.94M
Beneficio neto
-5.83M

Acerca de Softing

Sector
Cmp Integrated Sys Design
Industria
Communications Equipment
Sitio web
www.softing.com
Sede
Munich, Deu
Fundado
1979
Softing is listed in the Cmp Integrated Sys Design sector of the Tradegate (DE) with ticker SYT. The last closing price for Softing was 3.16 €. Over the last year, Softing shares have traded in a share price range of 2.86 € to 5.75 €.

Softing currently has 9,105,291 shares in issue. The market capitalisation of Softing is 28.77 € million. Softing has a price to earnings ratio (PE ratio) of -10.47.

SYT Últimas noticias

Más noticias
No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.041.265822784813.163.282.9432913.06548106DE
4-0.18-5.325443786983.383.462.8656003.04036333DE
12-1.12-25.92592592594.324.582.8628963.39607986DE
26-1.4399999-31.03448127234.63999994.982.8619373.73279163DE
52-2.05-39.04761904765.255.752.8616504.41090368DE
156-3.62-53.07917888566.827.822.8623285.77438802DE
260-4.88-60.3960396048.088.222.8633155.88828631DE

SYT - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Softing?
El precio actual de las acciones de Softing es 3.20 €
¿Cuántas acciones de Softing están en circulación?
Softing tiene 9,105,291 acciones en circulación
¿Cuál es la capitalización de mercado de Softing?
La capitalización de mercado de Softing es EUR 28.77M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Softing?
Softing ha negociado en un rango de 2.86 € a 5.75 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Softing?
El ratio precio/beneficio de Softing es -10.47
¿Cuál es el ratio de efectivo a ventas de Softing?
El ratio de efectivo a ventas de Softing es 0.54
¿Cuál es la moneda de reporte de Softing?
Softing presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Softing?
El último ingresos anual de Softing es EUR 113.94M
¿Cuál es el último beneficio anual de Softing?
El último beneficio anual de Softing es EUR -5.83M
¿Cuál es la dirección registrada de Softing?
La dirección registrada de Softing es RICHARD-REITZNER-ALLEE 6, MUNICH, 85540
¿Cuál es la dirección del sitio web de Softing?
La dirección del sitio web de Softing es www.softing.com
¿En qué sector industrial opera Softing?
Softing opera en el sector COMMUNICATIONS EQUIPMENT

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
0S6Cerence Inc
18.972 €
(145.34%)
90.04k
CY9DMicrobot Medical Inc
2.11 €
(89.07%)
24.21k
RV0Torrent Gold Inc
0.138 €
(73.58%)
1.23k
7CCCheckCap Ltd
1.76 €
(55.75%)
6.55k
34Q0Quantum eMotion Inc
0.985 €
(53.91%)
1.62M
7DBDiamondback Energy Inc
9.7176 €
(-94.02%)
800
FASFastenal Co
9.7358 €
(-85.95%)
2.13k
1UR1Bee Vectoring Technologies International Inc
0.003 €
(-45.45%)
300.18k
B4T0CuFe Ltd
0.0045 €
(-25.00%)
1
H5EHelma Eigenheimbau Ag
0.0766 €
(-23.40%)
751
PF8European Lithium Limited
0.0264 €
(8.20%)
5.76M
3CPXiaomi Corporation
4.597 €
(7.34%)
3.95M
D7GNel ASA
0.247 €
(2.66%)
2.33M
J9AVERSES AI Inc
1.352 €
(0.00%)
1.67M
34Q0Quantum eMotion Inc
0.985 €
(53.91%)
1.62M

Discusión

Ver feed completo
DonVance DonVance 4 minutos hace
This will hit 1k this year I believe now.
MSTR
georgejjl georgejjl 5 minutos hace
How many of the 7 million Alzheimer’s patients in the USA are projected to be treated with the MAB infusions during 2025???

How many people with Alzheimer’s in the USA are projected to be treated with donepezil (Aricept) or memantine during 2025???

The treatment used t
AVXL
Mr. Bill Mr. Bill 5 minutos hace
Stretches https://www.healthline.com/health/back-pain/sciatic-stretches#sitting-spinal-stretch
Graniteguy Graniteguy 7 minutos hace
Doc and Investor posters here tend to be negatively biased which you whole heartedly champion, especially "Doc" who's medical opinion is at best questionable, and incredibly biased, to fit a narrative of constant failure for Anavex's Blarcamesine. The fact that you pile onto their "steaming pile of
AVXL
BDEZ BDEZ 8 minutos hace
The Russes hit the jackpot?
BDEZ BDEZ 10 minutos hace
40% of homicides in the US take place in districts with a Soros-funded prosecutor.

Biden gave him a Medal Of Freedom.

https://x.com/EndWokeness/status/1875725808071012529
BDEZ BDEZ 10 minutos hace
Not good, thanks for sharing.
sand sand 17 minutos hace
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 17 minutos hace
Moving hard soon 
EFSH
mining101 mining101 19 minutos hace
Superb
MEGL
benz280c benz280c 26 minutos hace
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 32 minutos hace
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 33 minutos hace
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 36 minutos hace
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 42 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 42 minutos hace
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD
sunspotter sunspotter 47 minutos hace
Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
Investor2014 Investor2014 50 minutos hace
The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
AVXL
nowwhat2 nowwhat2 50 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
sunspotter sunspotter 53 minutos hace
I rather think you missed the point. It’s not that higher doses of GALT’s drug are toxic, it’s that they are ineffective.

Given the purported mechanism, that almost certainly means lower doses are too, and that the implication that the lower dose worked is merely an artefact.
GALT
nowwhat2 nowwhat2 55 minutos hace
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
XRPUSD
CrossFireTrader CrossFireTrader 58 minutos hace
I try to avoid Krispy Kreme's af all costs. Thanks for your insight...
GDVM
skitahoe skitahoe 59 minutos hace
Dstock, you may be very right about the data from compassionate use being included, but if it is, I would think that the protocols used on every one of those patients would need to be included as none are specifically on the trial protocol. It's essentially anecdotal evidence, but it could all add
NWBO

Su Consulta Reciente

TG
SYT
Softing
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados